LONDON (ShareCast) - (ShareCast News) - NetScientific has been granted its first European patent for non-invasive technology to measure glucose level in the blood via contact with the skin, a potentially important development for diabetes sufferers.
The granting of a patent on the product, which was co-developed by its Glucosense Diagnostics partnership and the University of Leeds, was a significant step in preparing the ground for commercial launch within the next three years, the company said.

The company is also developing a non-invasive wearable device to continuously monitor glucose levels, according to David Gough, head of European investments and operations for NetScientific, saying this product could replace implanted devices for people with the severe Type I diabetes.

This wearable tech will also help people with lifestyle-induced Type 2 diabetes - a much larger and rapidly growing population.

As of 12:15 BST, NetScientific was trading 1.6% lower at 190p.

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE